| Methods |
Adequate allocation generation, open, no ITT |
| Participants |
Nursing students, Cairo |
| Interventions |
Azythromycin: 1 x 500 mg versus rifampin: 4 x 600 mg |
| Outcomes |
Eradication, reacquisition, resistance developed, adverse effects
Follow‐up: 2 weeks |
| Notes |
Main serogroups: A, B |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Random sequence generation (selection bias) |
Low risk |
Adequate allocation generation |
| Allocation concealment (selection bias) |
Unclear risk |
Unclear |
| Blinding of participants and personnel (performance bias)
All outcomes |
High risk |
Open |
| Blinding of outcome assessment (detection bias)
All outcomes |
High risk |
Open |
| Incomplete outcome data (attrition bias)
All outcomes |
Unclear risk |
No ITT |
| Selective reporting (reporting bias) |
Low risk |
No evidence |
| Other bias |
Low risk |
No evidence |
